ORIGINAL RESEARCH
Accepted on 02 Sep 2025
Generation of novel human anti-OX-40 mAbs endowed with different biological properties as tools for cancer therapy
doi 10.3389/fimmu.2025.1644391
- 570 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Crosstalk in Tumor Microenvironments: Shaping Early Drug and Immunotherapy Strategies
Crosstalk in Tumor Microenvironments: Shaping Early Drug and Immunotherapy Strategies
8,547
Total downloads
29k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 16 Jul 2025
Identification of CTSC-driven progression in ESCC by single-cell sequencing and experimental validation
doi 10.3389/fimmu.2025.1585139
- 1,040 views
ORIGINAL RESEARCH
Published on 14 May 2025
Construction of a stromal cell-related prognostic signature based on a 101-combination machine learning framework for predicting prognosis and immunotherapy response in triple-negative breast cancer
doi 10.3389/fimmu.2025.1544348
- 3,027 views
REVIEW
Published on 28 Feb 2025
Central nervous system and immune cells interactions in cancer: unveiling new therapeutic avenues
doi 10.3389/fimmu.2025.1528363
- 2,751 views
- 2 citations
ORIGINAL RESEARCH
Published on 12 Feb 2025
Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis
doi 10.3389/fimmu.2025.1491450
- 2,199 views
ORIGINAL RESEARCH
Published on 10 Feb 2025
Developing transcriptomic biomarkers for TAVO412 utilizing next generation sequencing analyses of preclinical tumor models
doi 10.3389/fimmu.2025.1505868
- 1,659 views
- 1 citation
CASE REPORT
Published on 27 Jan 2025
Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review
doi 10.3389/fimmu.2025.1513604
- 2,339 views
REVIEW
Published on 25 Nov 2024
Stanniocalcin-1 in tumor immunity: acts via macrophages
doi 10.3389/fimmu.2024.1510182
- 1,526 views
- 2 citations
SYSTEMATIC REVIEW
Published on 01 Nov 2024
Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of advanced colorectal cancer: a systematic review and meta-analysis
doi 10.3389/fimmu.2024.1485303
- 3,456 views
- 10 citations
ORIGINAL RESEARCH
Published on 31 Oct 2024
E2F1-induced autocrine IL-6 inflammatory loop mediates cancer-immune crosstalk that predicts T cell phenotype switching and therapeutic responsiveness
doi 10.3389/fimmu.2024.1470368
- 2,510 views
- 3 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Vaccines and Molecular Therapeutics
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore